Medicare negotiated the price of 10 popular medications to save enrollees money. Even more medications are scheduled for ...
The Centers for Medicare & Medicaid Services (CMS) has announced that its temporary program to cover GLP-1 drugs for obesity in Medicare.
5don MSN
A new Medicare program that uses AI for prior authorizations is hurting patients and delaying care
Six states are part of a pilot program by CMS to reduce “waste, fraud and abuse.” ...
The BALANCE program was intended to cover weight-loss drugs for Medicaid beneficiaries, but is delayed. A new solution with ...
The Centers for Medicare and Medicaid Services (CMS) and the U.S. Food and Drug Administration (FDA) announced on Thursday ...
The Centers for Medicare & Medicaid Services (CMS) will extend its temporary Medicare GLP-1 Bridge program for obesity drug coverage through the end of 2027, delaying the launch of a longer-term model ...
Congress has an obligation to direct the Centers for Medicare and Medicaid Services to partner with state Medicaid leaders ...
The Legislative Budget Commission on Tuesday approved two requests from the Agency for Health Care Administration to give it ...
Industry stakeholders left a recent meeting with Centers for Medicare & Medicaid Services (CMS) Administrator Dr. Mehmet Oz ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results